Anticoagulation after coronary stenting: a systemic review | Zendy

Zhe Dong | Zendy; Jingang Zheng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Anticoagulation after coronary stenting: a systemic review

Author(s) -

Zhe Dong,

Jingang Zheng

Publication year - 2017

Publication title -

british medical bulletin

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 1.08

H-Index - 112

eISSN - 1471-8391

pISSN - 0007-1420

DOI - 10.1093/bmb/ldx018

Subject(s) - medicine , bivalirudin , prasugrel , anticoagulant , conventional pci , intensive care medicine , discovery and development of direct thrombin inhibitors , direct thrombin inhibitor , regimen , ticagrelor , clinical trial , percutaneous coronary intervention , warfarin , dabigatran , atrial fibrillation , myocardial infarction , thrombin , platelet

Anticoagulant therapy is mainly used to prevent patients from suffering coronary and systemic thromboembolism after stenting. Many studies have been done to formulate an optimized regimen of a post-PCI or long-time anticoagulant therapy. Recent advances in the selection and duration of anticoagulant agents will be conducive to the management of patients who are considered to need anticoagulant therapy after stenting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research